Cryolife reported $40.38M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Accuray ARAY:US $ 88.74M 9.1M
Atricure ATRC:US $ 54.56M 26.42M
Baxter International BAX:US $ 1852M 442M
Becton, Dickinson and BDX:US $ 2558M 589M
Cardiovascular Systems CSII:US $ 66.42M 0.53M
Cryolife CRY:US $ 40.38M 11.03M
Edwards Lifesciences EW:US $ 1198.1M 167.2M
Inogen INGN:US $ 223.62M 10.22M
Integra Lifesciences IART:US $ 447.15M 40.06M
Mesa Laboratories MLAB:US $ 43.75M 5.6M
Natus Medical BABY:US $ 84.28M 8.69M
Orthofix International OFIX:US $ 59.54M 12.38M
Resmed RMD:US $ 273.71M 71.94M
Stryker SYK:US $ 1044M 414M
Surmodics SRDX:US $ 20.07M 4.64M
Tandem Diabetes Care TNDM:US $ 114.97M 21.28M
Teleflex TFX:US $ 308.12M 158.54M
Terumo 4543:JP Y 209566M 4315M
Trinity Biotech TRIB:US $ 10.01M 15.9M